Back to CLDX Stock Lookup

Celldex (CLDX) – Company Press Releases

Aug 10, 2015 04:01 PM Celldex Reports Second Quarter 2015 Results
Aug 4, 2015 09:20 AM Celldex to Report Second Quarter 2015 Financial Results and Host Corporate 2015 Objectives Update Call
Aug 4, 2015 09:20 AM Celldex to Report Second Quarter 2015 Financial Results and Host Corporate 2015 Objectives Update Call
Jul 2, 2015 08:00 AM Celldex Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
Jul 2, 2015 08:00 AM Celldex Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
Jul 1, 2015 08:00 AM Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
Jun 29, 2015 08:00 AM Independent Data Safety and Monitoring Board Recommends Continuation of Celldex's Phase 3 Study of RINTEGA(R) (rindopepimut) in Newly Diagnosed Glioblastoma
Jun 29, 2015 08:00 AM Independent Data Safety and Monitoring Board Recommends Continuation of Celldex's Phase 3 Study of RINTEGA(R) (rindopepimut) in Newly Diagnosed Glioblastoma
May 31, 2015 09:00 AM Randomized Phase 2 ReACT Study of RINTEGA(R) in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Overall Survival and Emergence of Long-term Survival Benefit; Primary En
May 31, 2015 09:00 AM Randomized Phase 2 ReACT Study of RINTEGA(R) in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Overall Survival and Emergence of Long-term Survival Benefit; Primary En
May 28, 2015 09:21 AM Celldex Therapeutics Initiates Phase 1/2 Study of Varlilumab in Combination with Sunitinib in Metastatic Clear Cell Renal Cell Carcinoma
May 28, 2015 09:21 AM Celldex Therapeutics Initiates Phase 1/2 Study of Varlilumab in Combination with Sunitinib in Metastatic Clear Cell Renal Cell Carcinoma
May 27, 2015 04:01 PM Celldex Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference
May 27, 2015 04:01 PM Celldex Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference
May 13, 2015 05:08 PM Celldex Therapeutics to Present Data from the ReACT Study at 2015 ASCO Annual Meeting
May 13, 2015 05:08 PM Celldex Therapeutics to Present Data from the ReACT Study at 2015 ASCO Annual Meeting
Apr 29, 2015 08:01 AM Celldex Reports First Quarter 2015 Results
Apr 29, 2015 08:01 AM Celldex Reports First Quarter 2015 Results
Apr 20, 2015 08:01 AM Celldex's Varlilumab Demonstrates Synergistic Anti-Tumor Activity with PD-1 Signaling Blockade in Preclinical Studies
Apr 20, 2015 08:01 AM Celldex's Varlilumab Demonstrates Synergistic Anti-Tumor Activity with PD-1 Signaling Blockade in Preclinical Studies
Apr 6, 2015 04:01 PM Celldex Therapeutics' Phase 2 EMERGE Study of Glembatumumab Vedotin in Metastatic Breast Cancer Published in Journal of Clinical Oncology
Apr 6, 2015 04:01 PM Celldex Therapeutics' Phase 2 EMERGE Study of Glembatumumab Vedotin in Metastatic Breast Cancer Published in Journal of Clinical Oncology
Apr 6, 2015 08:01 AM Celldex Therapeutics Announces Initiation of Phase 1/2 Study of Varlilumab in Combination with Ipilimumab and CDX-1401 in Metastatic Melanoma
Mar 17, 2015 08:01 AM Celldex Therapeutics Announces Clinical Trial Collaboration with Roche to Evaluate the Combination of Varlilumab and MPDL3280A
Feb 27, 2015 01:25 PM Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares
Feb 25, 2015 06:48 PM Celldex Therapeutics Prices Public Offering of Common Stock
Feb 24, 2015 04:00 PM Celldex Therapeutics Announces Proposed Public Offering of Common Stock
Feb 19, 2015 04:01 PM Celldex to Report Fourth Quarter and Fiscal 2014 Business/Financial Results and Host 2015 Corporate Strategy Conference Call
Dec 4, 2014 04:01 PM Celldex Therapeutics Initiates a Phase 2 Study of Glembatumumab Vedotin in Patients with Advanced Melanoma
Nov 7, 2014 10:01 AM Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014
Nov 4, 2014 04:01 PM Celldex Reports Third Quarter 2014 Results
Sep 25, 2014 08:05 AM Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation
Sep 3, 2014 02:00 PM Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference
Aug 6, 2014 04:01 PM Celldex Reports Second Quarter 2014 Results
Jul 30, 2014 08:03 AM Celldex Therapeutics Announces Senior Leadership Promotions
Jul 18, 2014 08:03 AM Celldex to Report Second Quarter 2014 Financial Results and Host Corporate 2014 Objectives Update Call
May 28, 2014 11:00 AM Celldex Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
May 14, 2014 05:01 PM Celldex Therapeutics Announces Varlilumab (CDX-1127) Phase 1 Clinical Data to be Presented at ASCO Annual Meeting 2014
May 2, 2014 11:45 AM Celldex to Present at Two Upcoming Investor Conferences

Back to CLDX Stock Lookup